Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa

By sjmartinez • June 23, 2023

Beesham I, Milford C, Smit J, Joseph Davey DL, Baeten JM, Heffron R, Beksinska M, Mansoor LE. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. BMC Public Health. 2023 Jun 22;23(1):1210. doi: 10.1186/s12889-023-16139-z. PMID: 37349816.

Tags: Infectious Diseases, Oral pre-exposure prophylaxis, Post-trial access and use, Publications, south africa, young women

High rate of uncontrolled hypertension among adults receiving integrated HIV and hypertension care with aligned multi-month dispensing in Malawi: results from a cross-sectional survey and retrospective chart review

Whitehead HS, Phiri K, Kalande P, van Oosterhout JJ, Talama G, Phiri S, Moucheraud C, Moses A, Hoffman RM. High rate of uncontrolled hypertension among[...]

Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection

Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein[...]

Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysin

Lin J, Miao J, Schaefer KG, Russell CM, Pyron RJ, Zhang F, Phan QT, Solis NV, Liu H, Tashiro M, Dordick JS, Linhardt RJ, Yeaman[...]